Notice: This company recently went public with an IPO on Friday, January 31st 2025. They issued 8,750,000 shares at $16.00 per share. We will continue to update data for MAZE as it becomes available.

Maze Therapeutics (MAZE) SEC Filings & 10K Form

Maze Therapeutics logo
$12.96 -0.42 (-3.14%)
As of 02/10/2025 04:00 PM Eastern

Recent Maze Therapeutics SEC Filings

DateFilerForm TypeView
02/07/2025
3:30 PM
Deep Track Capital, LP (Filed by)
Maze Therapeutics (Subject)
Form SCHEDULE 13G
02/04/2025
4:31 PM
Maze Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures GP V, LP (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
Third Rock Ventures V, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
TRV GP V, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:35 PM
HOMCY CHARLES J (Reporting)
Maze Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:37 PM
Lim Jonathan E (Reporting)
Maze Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:21 PM
Maze Therapeutics (Filer)
Form 424B4
01/31/2025
4:30 PM
Maze Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/30/2025
11:15 PM
Maze Therapeutics (Filer)
Form EFFECT
01/30/2025
7:55 PM
Maze Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures GP V, LP (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
Third Rock Ventures V, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
TRV GP V, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
5:40 PM
Maze Therapeutics (Filer)
Form S-1MEF
01/30/2025
3:38 PM
Maze Therapeutics (Issuer)
SPIEGELMAN DANIEL K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:39 PM
Maze Therapeutics (Issuer)
Tong Jeffrey K (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:21 PM
Bachrodt Amy (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:22 PM
Bernstein Harold (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:24 PM
Courtney Phillips (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:25 PM
Andrews Nancy C (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:27 PM
Brush James (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:28 PM
Colowick Alan (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:29 PM
Exter Neil (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:31 PM
HOMCY CHARLES J (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:33 PM
Kathiresan Sekar (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
3:34 PM
Lim Jonathan E (Reporting)
Maze Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/30/2025
5:57 AM
Maze Therapeutics (Filer)
Form S-1/A
01/27/2025
3:05 PM
Maze Therapeutics (Filer)
Form 8-A12B
01/27/2025
5:07 AM
Maze Therapeutics (Filer)
Form S-1/A
01/07/2025
3:16 PM
Maze Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MAZE) was last updated on 2/11/2025 by MarketBeat.com Staff
From Our Partners